ATE371453T1 - Verfahren zur behandlung von okularen neovaskularen erkrankungen - Google Patents

Verfahren zur behandlung von okularen neovaskularen erkrankungen

Info

Publication number: ATE371453T1
Authority: AT; Austria
Prior art keywords: occular; treating; neovascular diseases; neovascular; diseases
Prior art date: 1998-08-13

Application number

AT99944371T

Other languages

English (en)

Inventor

Romulus Brazzell

Jeanette Wood

Peter Campochiaro

Frances Kane

Original Assignee

Novartis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-13

Filing date

1999-08-11

Publication date

2007-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22460608&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE371453(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-08-11 Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh

2007-09-15 Application granted granted Critical

2007-09-15 Publication of ATE371453T1 publication Critical patent/ATE371453T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

AT99944371T 1998-08-13 1999-08-11 Verfahren zur behandlung von okularen neovaskularen erkrankungen ATE371453T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US13385598A	1998-08-13	1998-08-13

Publications (1)

Publication Number	Publication Date
ATE371453T1 true ATE371453T1 (de)	2007-09-15

Family

ID=22460608

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99944371T ATE371453T1 (de)	1998-08-13	1999-08-11	Verfahren zur behandlung von okularen neovaskularen erkrankungen

Country Status (12)

Country	Link
EP (1)	EP1105136B1 (de)
JP (1)	JP2002522475A (de)
AR (1)	AR028802A1 (de)
AT (1)	ATE371453T1 (de)
AU (1)	AU5733099A (de)
CY (1)	CY1107780T1 (de)
DE (1)	DE69936994T2 (de)
DK (1)	DK1105136T3 (de)
ES (1)	ES2291041T3 (de)
PT (1)	PT1105136E (de)
TW (1)	TWI239243B (de)
WO (1)	WO2000009098A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CO4950519A1 (es) *	1997-02-13	2000-09-01	Novartis Ag	Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
AU8816298A (en)	1997-08-22	1999-03-16	Zeneca Limited	Oxindolylquinazoline derivatives as angiogenesis inhibitors
CN1221262C (zh) *	1999-03-30	2005-10-05	诺瓦提斯公司	治疗炎性疾病的酞嗪衍生物
US7087608B2 (en) *	2000-03-03	2006-08-08	Robert Charles Atkins	Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
JP2004537537A (ja)	2001-06-29	2004-12-16	アブサイエンス	炎症性疾患を治療するためのチロシンキナーゼ阻害剤の使用法
WO2003002106A2 (en)	2001-06-29	2003-01-09	Ab Science	Use of tyrosine kinase inhibitions for treating allergic diseases
US7727731B2 (en)	2001-06-29	2010-06-01	Ab Science	Potent, selective and non toxic c-kit inhibitors
ATE343415T1 (de)	2001-06-29	2006-11-15	Ab Science	Die verwendung von c-kit hemmer zur behandlung von entzündlichen darmerkrankungen
GB0122318D0 (en) *	2001-09-14	2001-11-07	Novartis Ag	Organic compounds
CA2461183A1 (en) *	2001-09-20	2003-05-15	Ab Science	Use of tyrosine kinase inhibitors for whitening human skin and treating melanocyte dysfunction associated diseases
CA2477558A1 (en) *	2002-02-28	2003-09-04	Novartis Ag	N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents
WO2003092696A1 (en) *	2002-04-30	2003-11-13	Novartis Ag	Method for decreasing capillary permeability in the retina
US9073997B2 (en)	2007-02-02	2015-07-07	Vegenics Pty Limited	Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH09316099A (ja) *	1995-08-21	1997-12-09	Mitsui Petrochem Ind Ltd	抗ｖｅｇｆヒトモノクローナル抗体
US6514971B1 (en) *	1996-03-15	2003-02-04	Zeneca Limited	Cinnoline derivatives and use as medicine
AU2066797A (en) *	1996-03-21	1997-10-10	Sugen, Inc.	Assays for kdr/flk-1 receptor tyrosine kinase inhibitors
UA54427C2 (uk) *	1996-05-01	2003-03-17	Елі Ліллі Енд Компані	Спосіб лікування очних захворювань, які пов'язані з фактором васкулярного ендотеліального росту
JPH1031019A (ja) *	1996-07-15	1998-02-03	Toagosei Co Ltd	糖尿病性血管新生緑内障の検査方法及び検査薬
AU733551B2 (en) *	1996-09-25	2001-05-17	Astrazeneca Ab	Qinoline derivatives inhibiting the effect of growth factors such as VEGF
CO4950519A1 (es) *	1997-02-13	2000-09-01	Novartis Ag	Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion

1999
- 1999-08-11 AT AT99944371T patent/ATE371453T1/de not_active IP Right Cessation
- 1999-08-11 JP JP2000564601A patent/JP2002522475A/ja not_active Withdrawn
- 1999-08-11 WO PCT/EP1999/005876 patent/WO2000009098A2/en active IP Right Grant
- 1999-08-11 ES ES99944371T patent/ES2291041T3/es not_active Expired - Lifetime
- 1999-08-11 DK DK99944371T patent/DK1105136T3/da active
- 1999-08-11 DE DE69936994T patent/DE69936994T2/de not_active Expired - Lifetime
- 1999-08-11 AU AU57330/99A patent/AU5733099A/en not_active Abandoned
- 1999-08-11 AR ARP990104021A patent/AR028802A1/es unknown
- 1999-08-11 EP EP99944371A patent/EP1105136B1/de not_active Expired - Lifetime
- 1999-08-11 PT PT99944371T patent/PT1105136E/pt unknown
- 1999-08-12 TW TW088113778A patent/TWI239243B/zh not_active IP Right Cessation
2007
- 2007-10-25 CY CY20071101385T patent/CY1107780T1/el unknown

Also Published As

Publication number	Publication date
AR028802A1 (es)	2003-05-28
WO2000009098A2 (en)	2000-02-24
DE69936994T2 (de)	2008-06-05
WO2000009098A3 (en)	2000-05-18
DE69936994D1 (de)	2007-10-11
PT1105136E (pt)	2007-12-03
TWI239243B (en)	2005-09-11
JP2002522475A (ja)	2002-07-23
EP1105136B1 (de)	2007-08-29
EP1105136A2 (de)	2001-06-13
CY1107780T1 (el)	2013-06-19
ES2291041T3 (es)	2008-02-16
DK1105136T3 (da)	2007-10-15
AU5733099A (en)	2000-03-06

Similar Documents

Publication	Publication Date	Title
DE69806970D1 (de)	2002-09-05	Verfahren zur behandlung von hartgeweben
DE69939058D1 (de)	2008-08-21	Vorrichtung zur behandlung von peripheren gefässerkrankungen
DE60122532D1 (de)	2006-10-05	Verfahren zur behandlung von mehreren bohrlochintervallen
DE69807868D1 (de)	2002-10-17	Verfahren zur behandlung von abwasserstroemen
ATE296915T1 (de)	2005-06-15	Verfahren zur textilbehandlung
DE69925266D1 (de)	2005-06-16	Verfahren und gerät zur behandlung von herzarhythmie
DE69838789D1 (de)	2008-01-10	Verfahren zur behandlung oder prävention der alzheimerischen krankheit
DE69816070D1 (de)	2003-08-07	Verfahren zur Behandlung von Schredderstaub
DE69603838D1 (de)	1999-09-23	Verfahren zur behandlung von gasen
DE69624116T2 (de)	2003-06-18	Verfahren zur behandlung von allergischem asthma
DE69714828D1 (de)	2002-09-26	Verfahren zur Behandlung von Abfallstoffen
DE69928534D1 (de)	2005-12-29	Verfahren zur behandlung flüssiger ströme
ATE257189T1 (de)	2004-01-15	Verfahren zur behandlung von cellulosischen formkörpern
ATE239457T1 (de)	2003-05-15	Verfahren zur prophylaktischen behandlung von mastitis
ATE371453T1 (de)	2007-09-15	Verfahren zur behandlung von okularen neovaskularen erkrankungen
DE69937624D1 (de)	2008-01-10	Verfahren zur Behandlung von Metalloberflächen
DE69912254D1 (de)	2003-11-27	Kosmetisches verfahren zur hautbehandlung
DE69834578D1 (de)	2006-06-22	Verfahren zur behandlung von zementaufschlämmungen
DE60021948D1 (de)	2005-09-22	Verfahren zur Behandlung von Kontaktlinsen
DE69609082T2 (de)	2001-03-15	Verfahren zur behandlung von abfällen
DE69904849T2 (de)	2003-11-13	3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
DE69921623D1 (de)	2004-12-09	Verfahren zur Behandlung von Entwässerungsflüssigkeit
ATE307871T1 (de)	2005-11-15	Verfahren zur behandlung von gewebe
DE69802904T2 (de)	2002-08-29	Verbessertes verfahren zur behandlung von aluminiummonohydratreichen bauxiten
DE69905263D1 (de)	2003-03-13	Verfahren zur dekorativen behandlung von oberflächen

Legal Events

Date

Code

Title

Description

2007-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1105136

Country of ref document: EP

2011-05-15

REN

Ceased due to non-payment of the annual fee